Cori Clinical secures $4M seed to improve clinical trial design and cut delays

Cori Clinical, an AI platform for clinical trials, has raised $4 million in a seed funding round led by Breega, with participation from Enzo, Heartfelt, Together Ventures and Bynd. The company is targeting the fragmented processes and disconnected sources of information involved in designing and setting up clinical trials. Cori was founded by Jorn Jansen Schoonhoven (CEO) and Patricio Fernández (CTO). The company has developed an AI workspace that brings together an organisation’s knowledge from previous clinical trials with external intelligence from trial registries, regulatory guidance and public sources, including the US Food and Drug Administration (FDA), the UK Medicines and Healthcare Products Regulatory Agency (MHRA) and the European Medicines Agency (EMA). The platform helps clinical teams turn an initial trial brief into a full protocol, submission package and operational plans based on current regulatory guidance. Rather than focusing on an individual document or workflow, C